LC Sciences and DNAVision form Strategic Marketing Alliance
on: May 6, 2008, 5:41 am
Release Author: firstname.lastname@example.org
Release Summary: LC Sciences announced today that it has entered
into a strategic marketing alliance with DNAVision to increase
accessibility to its custom microRNA profiling service and enhance
both its customer and technical service to researchers in Europe.
LC Sciences’ microRNA profiling service is powered by µParaflo®
microfluidic technology and makes use of flexible custom microarrays
for expression profiling as well as discovery of novel small RNAs
and validation of predicted microRNAs. DNAVision, specialized
in molecular biology, provides a wide range of genetic services
and products to the pharmaceutical, food, and biotechnology industries.
Release Body: Houston, TX – May 6, 2008 – LC
Sciences announced today that it has entered into a strategic
marketing alliance with DNAVision to increase
accessibility to its custom microRNA profiling
service and enhance both its customer and technical service to
researchers in Europe. LC Sciences’ microRNA profiling
service is powered by µParaflo® microfluidic
technology and makes use of flexible custom microarrays for expression
profiling as well as discovery of novel small RNAs and validation
of predicted microRNAs. DNAVision,
specialized in molecular biology, provides a wide range of genetic
services and products to the pharmaceutical, food, and biotechnology
“We are very excited about this alliance with DNAVision,
clearly one of the quality leaders of microarray and other molecular
biology services,” says Chris Hebel, Director
of Business Development at LC Sciences. “Although
we are currently serving customers globally from our headquarters
in the U.S., we felt is was important to extend our reach and
provide local service to areas where there is a concentration
of microRNA research occurring, like Europe.
DNAVision has extensive microarray and
microRNA expertise in-house and can provide not only
ordering convenience but also real technical guidance to researchers
in this rapidly advancing field.”
“We are delighted to combine our quality gene expression
services with the technology developed by LC Sciences.”
said Jean-Pol Detiffe, CEO of DNAVision. “This
agreement is a new evidence that DNAVision is
becoming the technical partner of choice for microRNA expression
profiling, using all the latest technologies available on the
market” added Michäel Herman, DNAVision,
Business Development Director.
MicroRNAs and other small RNAs found in non-coding
regions of genomes have recently been found to regulate the expression
of genes acting in a wide range of biology systems. The study
of microRNA has attracted intense attention and
is a rapidly evolving field. Although the regulatory functions
of many known microRNAs are still not fully understood, many more
microRNAs are continually being discovered. The number of microRNA
sequences in the public database (miRBase) has been increasing
steadily as new microRNAs are experimentally
verified and deposited there. Especially in this rapidly evolving
field, it is important for scientists to have access to the most
up to date information and research tools.
The µParaflo® technology is a unique
combination of microfluidics, digital photolithography, and novel
synthesis chemistry that enables on chip synthesis of custom microarrays.
On chip synthesis (vs. spotting) of the most up to date microRNA
probes sequences from miRBase ensures that researchers have the
most complete picture of microRNA expression
in their samples and, through the use of completely custom microarrays,
allows for discovery of novel small RNAs as well as validation
of computationally predicted microRNAs.
About µParaflo® Technology - The
µParaflo® technology is a microfluidic platform
for in situ parallel synthesis of biomolecular chips and miniturization
of bioassays including binding and enzymatic reactions. This unique
platform technology is based on a new class of three-dimensional
pico-liter microfluidic reaction devices, and a digital light
controlled synthesis method that employs conventional oligonucleotide
or peptide synthesis chemistry; a completely programmable process.
The seamless integration of these multidisciplinary technologies
enables a signifcant advance in parallelization, miniaturization,
customization, and automation.
About LC Sciences - LC Sciences
is a genomics and proteomics products company offering a comprehensive
line of DNA, RNA, and peptide microarrays for nucleic acid/protein
profiling and functional analysis, biomarker-discovery, novel
drug screening, and the custom development of miniaturized assay
devices for diagnostics and biosensing applications. Based on
the µParaflo® microfluidics technology,
LC Sciences’ innovative products offer
significant flexibility and customization capability for rapidly
evolving, diverse customer needs. In an era of rapid technological
advancement, LC Sciences offers service products
which enable efficient one-stop solution for assays of DNA, RNA,
protein, enzymes, antibodies, or small molecules. LC Sciences
also provides unique synthetic DNA and RNA products such as OligoMix®,
generated using their microfludic biochip synthesizer. These innovative
products drive synthetic biology and systems biology applications
by reducing the cost and increasing the speed of highly multiplexing
large-scale nucleic acid and protein engineering experiments.
More information about LC Sciences is available at www.lcsciences.com.
DNAVision is a leading provider of applied pharmacogenetic
& pharmacogenomic services. DNAVision offers
the powerful combination of different technologies in expression
profiling, SNP genotyping and sequencing in a high quality environment.
DNAVision is a spin-off of Free University of
Brussels and Institute of Pathology and Genetics. DNAVision
is the first full-service pharmacogenomic laboratory to be ISO17025
accredited, GLP certified and CLIA.
information on DNAVision’s service portfolio can be found
Details: Chris Hebel
Tel. +32 71 378 527
Fax. +32 71 378 501